EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Genotype and phenotype spectrum of Charcot-Marie-Tooth disease due to mutations in SORD

Andrea Cortese iD, Maike F Dohrn iD, Riccardo Curro, Sara Negri, Petra Lassuthova, Chiara Pisciotta iD, Stefano Tozza iD, Abdullah Al-Ajmi, Changyong Feng, Pedro J Tomaselli iD, Gorka Fernandez-Eulate, Saif Haddad und 48 weitere

Brain · 2025

DOI: 10.1093/brain/awaf021 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Brain, 2025. Verfasst von Andrea Cortese und 59 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK. Hauptthemen laut MEDLINE: Charcot-Marie-Tooth Disease, Mutation, L-Iditol 2-Dehydrogenase. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NRRP, Fondazione Cariplo, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biallelic loss-of-function mutations in the sorbitol dehydrogenase (SORD) gene cause the most common recessive type of Charcot-Marie-Tooth disease (CMT), CMT-SORD. However, the full genotype-phenotype spectrum and progression of the disease remain to be defined. Notably, a multicentre phase 2/3 study to test the efficacy of govorestat (NCT05397665), a new aldose reductase inhibitor, is currently ongoing. Diagnosing CMT-SORD will become imperative when disease-modifying therapies become available. In this cross-sectional multicentre study, we identified 144 patients from 126 families, including 99 males (69%) and 45 females (31%). Patients represented multiple ancestries, including European, Hispanic, Chinese, Near Eastern and Northern African. We confirmed c.757delG (p.Ala253GlnfsTer27) as the most common pathogenic allele, followed by c.458C>A (p.Ala153Asp), while other variants were identified, mostly in single cases. The average sorbitol level in CMT-SORD patients was significantly higher compared to controls and heterozygous carriers, independently from serum storage duration, sex or variant type. Two-thirds of cases were diagnosed with CMT2 while one-third had distal hereditary motor neuropathy. Disease onset was usually in the second decade of life. Although foot dorsiflexion was the most affected muscle group, dorsal and plantar flexion had a similar degree of weakness in most cases (difference of Medical Research Council score ≤ 1). One-fourth of patients used ankle foot orthoses, usually in their 30s, but most patients maintained independent ambulation later in life. Nerve conduction studies were suggestive of a motor predominant axonal neuropathy, with reduced conduction velocities in the intermediate range in a quarter of the cases. Sensory conductions in the upper limbs appeared more frequently affected than in the lower limbs. Foot dorsiflexion and plantar flexion decreased significantly with age. Male sex was significantly associated with the severity of distal lower limb weakness (plantar flexion) and a larger change over time (dorsiflexion). In conclusion, CMT-SORD is a frequent recessive form of axonal, motor predominant CMT, with prominent foot dorsiflexion and plantar flexion involvement. Fasting serum sorbitol is a reliable biomarker of the condition that can be utilized for pathogenicity assessment of identified rare SORD variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Charcot-Marie-Tooth DiseaseMutationL-Iditol 2-DehydrogenaseHumansMaleFemaleAdultMiddle AgedCross-Sectional StudiesPhenotypeGenotypeAdolescentYoung AdultChildAgedSorbitol

Stichwörter der Autor:innen

SORDaldose reductasehereditary neuropathynatural historypolyol pathway

Substanzen

L-Iditol 2-DehydrogenaseSorbitol

Autor:innen und Institutionen

  • Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.
  • Department of Brain and Behavioral Sciences, University of Pavia, Pavia 27100, Italy.
  • Dr. John T. Macdonald Foundation, John P. Hussman Institute for Human Genomics, University of Miami, Miami, FL 33136, USA.
  • Department of Neurology, Medical Faculty, RWTH Aachen University, Aachen 52074, Germany.
  • Laboratorio di Epigenetica, Dipartimento Medicina Riabilitativa NeuroMotoria-MeRiNM, Istituti Clinici Scientifici Maugeri IRCCS, Pavia 27100, Italy.
  • Department of Paediatric Neurology, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Praha 150 06, Czechia.

ORCID-Profile: Andrea Cortese, Maike F Dohrn, Chiara Pisciotta, Stefano Tozza, Pedro J Tomaselli, James N Sleigh, Adriana Rebelo, Danique Beijer, Tyler Rehbein, Stefania Magri, Arman Cakar, Kishore R Kumar, Carlo Gaetano, Franco Taroni, Henry Houlden

Förderung

  • NRRP
  • Fondazione Cariplo
  • NIH HHS
  • NINDS NIH HHS
  • Deutsche Forschungsgemeinschaft
  • Medical Research Council
  • Ministry of University and Research
  • MNESYS

Zitieren

APA

Cortese, A., Dohrn, M. F., Curro, R., Negri, S., Lassuthova, P., Pisciotta, C., Tozza, S., Al-Ajmi, A., Feng, C., Tomaselli, P. J., Fernandez-Eulate, G., Haddad, S., Laurà, M., Rossor, A. M., Vegezzi, E., Facchini, S., Sleigh, J. N., Rebelo, A., Beijer, D., …, & Houlden, H. (2025). Genotype and phenotype spectrum of Charcot-Marie-Tooth disease due to mutations in SORD. Brain. https://doi.org/10.1093/brain/awaf021

Vancouver

Cortese A, Dohrn MF, Curro R, Negri S, Lassuthova P, Pisciotta C, et al. Genotype and phenotype spectrum of Charcot-Marie-Tooth disease due to mutations in SORD. Brain. 2025. doi:10.1093/brain/awaf021

BibTeX
@article{Cortese2025,
  author = {Cortese, Andrea and Dohrn, Maike F and Curro, Riccardo and Negri, Sara and Lassuthova, Petra and Pisciotta, Chiara and Tozza, Stefano and Al-Ajmi, Abdullah and Feng, Changyong and Tomaselli, Pedro J and Fernandez-Eulate, Gorka and Haddad, Saif and Laurà, Matilde and Rossor, Alexander M and Vegezzi, Elisa and Facchini, Stefano and Sleigh, James N and Rebelo, Adriana and Beijer, Danique and Raposo, Jacquelyn and Saporta, Mario and Lauerova, Barbora and Pernice, Helena F and Achenbach, Pascal and Schöne, Ulrike and Alon, Tayir and Deschauer, Marcus and Cordts, Isabell and Obermaier, Carolin D and Winter, Natalie and Creigh, Peter D and Sowden, Janet E and Rehbein, Tyler and Magri, Stefania and Bertini, Alessandro and Saveri, Paola and Ripellino, Paolo and Huang, Jingyu and Nadaj-Pakleza, Aleksandra and Ross, Alison and Holt, James K L and Brennan, Kathryn M and Sukenik-Halevy, Rivka and Bizaoui, Varoona and Parman, Yesim and Battaloglu, Esra and Cakar, Arman and Alrohaif, Hadil and Hammans, Simon and Kumar, Kishore R and Kennerson, Marina L and Kayserili, Hülya and Amado, Defne A and Hahn, Katrin and Valentino, Paola and Cavalcanti, Francesca and Gaetano, Carlo and Taroni, Franco and Braathen, Geir J and Houlden, Henry},
  title = {Genotype and phenotype spectrum of Charcot-Marie-Tooth disease due to mutations in SORD},
  journal = {Brain},
  year = {2025},
  doi = {10.1093/brain/awaf021}
}
Kostenlos starten →